Song Haoxin, Liu Xiao, Zou Kun, Li Hailong, Fei Haotian, Huang Liang, Yu Qin, Zhang Lingli
Department of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu, China.
Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu, China.
Arch Public Health. 2024 Oct 14;82(1):182. doi: 10.1186/s13690-024-01391-5.
The Access, Watch, and Reserve (AWaRe) classification of antibiotics was a useful tool to support antibiotic stewardship. However, the AWaRe patterns of antibiotic consumption in Western China were unclear. We aimed to assess the antibiotic consumption patterns using the AWaRe Classification of public hospitals in Sichuan Province Western China.
Antibiotic consumption data of year 2020 were obtained from the Sichuan Province Drug Use Monitoring Platform. We measured the antibiotic consumption (DDDs per 1,000 inhabitants per day, DIDs), calculated the proportion of antibiotic use, the ratio of Access to Watch antibiotics and patterns of antibiotic use by using drug utilization 90%.
This analysis included 4452 public health institutions. The antibiotic consumption rate was 10.39 DIDs (Median 8.50, IQR 7.71-12.96). The proportions of Access antibiotic use and Watch antibiotic use were 46.83% (Median 47.49, IQR 44.16-52.02) and 51.20% (Median 51.43, IQR 45.42-54.61), respectively. The Access-to-Watch index was 0.91 (Median 0.92, IQR 0.81-1.15). Amoxicillin (16.85%), cefuroxime (9.21%), cefixime (8.60%%), levofloxacin (8.11%) and metronidazole (6.16%) were the most consumed antibiotics.
The proportion of Access antibiotic consumption in Sichuan Western China has not achieved the WHO target of 60%. Overuse of antibiotic is serious in Sichuan. National and regional antibiotics management systems, stewardship programs and surveillance of antibiotic consumption based on AWaRe classification are needed to improve antibiotic consumption patterns, curb antibiotic overuse and combat antimicrobial resistance in Western China.
抗生素的准入、观察和储备(AWaRe)分类是支持抗生素管理的有用工具。然而,中国西部抗生素消费的AWaRe模式尚不清楚。我们旨在利用中国西部四川省公立医院的AWaRe分类评估抗生素消费模式。
2020年抗生素消费数据来自四川省药品使用监测平台。我们测量了抗生素消费量(每千居民每天的限定日剂量数,DIDs),计算了抗生素使用比例、准入类抗生素与观察类抗生素的比例以及使用药物利用90%的抗生素使用模式。
该分析纳入了4452家公共卫生机构。抗生素消费率为10.39 DIDs(中位数8.50,四分位间距7.71 - 12.96)。准入类抗生素使用比例和观察类抗生素使用比例分别为46.83%(中位数47.49,四分位间距44.16 - 52.02)和51.20%(中位数51.43,四分位间距45.42 - 54.61)。准入与观察指数为0.91(中位数0.92,四分位间距0.81 - 1.15)。阿莫西林(16.85%)、头孢呋辛(9.21%)、头孢克肟(8.60%)、左氧氟沙星(8.11%)和甲硝唑(6.16%)是消费最多的抗生素。
中国西部四川省准入类抗生素消费比例未达到世界卫生组织60%的目标。四川抗生素过度使用严重。需要基于AWaRe分类的国家和地区抗生素管理系统、管理计划以及抗生素消费监测,以改善抗生素消费模式,遏制抗生素过度使用并应对中国西部的抗菌药物耐药性问题。